Implementing TMB measurement in clinical practice: considerations on assay requirements

Clinical evidence demonstrates that treatment with immune checkpoint inhibitor immunotherapy agents can have considerable benefit across multiple tumours. However, there is a need for the development of predictive biomarkers that identify patients who are most likely to respond to immunotherapy. Com...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:ESMO Open
Huvudupphovsmän: Büttner, Reinhard, Longshore, John W, López-Ríos, Fernando, Merkelbach-Bruse, Sabine, Normanno, Nicola, Rouleau, Etienne, Penault-Llorca, Frédérique
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2019
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350758/
https://ncbi.nlm.nih.gov/pubmed/30792906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2018-000442
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk